Zeng KM - Search Results

1

HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer.

Luo F, Lu FT, Cao JX, Ma WJ, Xia ZF, Zhan JH, Zeng KM, Huang Y, Zhao HY, Zhang L. Luo F, et al. Among authors: zeng km. Cancer Lett. 2022 Apr 10;531:39-56. doi: 10.1016/j.canlet.2022.01.027. Epub 2022 Jan 26. Cancer Lett. 2022. PMID: 35090965 Free article.

2

Modification of the tumor response threshold in patients of advanced non-small cell lung cancer treated with chemotherapy plus targeted agents: a pooled study from five clinical trials in one institution.

Luo F, Zhang Z, Liao K, Zhang Y, Ma Y, Hu Z, Zeng K, Huang Y, Zhang L, Zhao H. Luo F, et al. Ann Transl Med. 2019 Jun;7(12):253. doi: 10.21037/atm.2019.04.65. Ann Transl Med. 2019. PMID: 31355220 Free PMC article.

3

Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis.

Zhang Z, Zhao Y, Lu F, Hou X, Ma Y, Luo F, Zeng K, Zhao S, Zhang Y, Zhou T, Yang Y, Fang W, Huang Y, Zhang L, Zhao H. Zhang Z, et al. Ann Transl Med. 2019 Sep;7(18):452. doi: 10.21037/atm.2019.08.51. Ann Transl Med. 2019. PMID: 31700888 Free PMC article.

4

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.

Zhang Z, Zeng K, Zhao S, Zhao Y, Hou X, Luo F, Lu F, Zhang Y, Zhou T, Ma Y, Yang Y, Fang W, Huang Y, Zhang L, Zhao H. Zhang Z, et al. Ther Adv Med Oncol. 2019 Dec 30;11:1758835919891652. doi: 10.1177/1758835919891652. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31908655 Free PMC article.

5

Prognostic value of serum high-density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery.

Luo F, Zeng KM, Zhang ZH, Zhou T, Zhan JH, Lu FT, Yang YP, Huang Y, Zhang L, Zhao HY. Luo F, et al. Among authors: zeng km. Clin Transl Med. 2020 Jun;10(2):e94. doi: 10.1002/ctm2.94. Epub 2020 Jun 5. Clin Transl Med. 2020. PMID: 32508010 Free PMC article. No abstract available.

6

Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.

Luo F, Lu FT, Qiu MZ, Zhou T, Ma WJ, Luo M, Zeng KM, Luo QY, Pan WT, Zhang L, Xia ZF, Zhang ZH, Cao JX, Zhao HY, Zhang L, Yang DJ. Luo F, et al. Among authors: zeng km. Cell Death Dis. 2021 Aug 5;12(8):772. doi: 10.1038/s41419-021-04042-7. Cell Death Dis. 2021. PMID: 34354046 Free PMC article.

7

Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in China.

Zhang Z, Luo F, Cao J, Lu F, Zhang Y, Ma Y, Zeng K, Zhang L, Zhao H. Zhang Z, et al. J Hematol Oncol. 2021 Aug 16;14(1):124. doi: 10.1186/s13045-021-01126-x. J Hematol Oncol. 2021. PMID: 34399818 Free PMC article.

8

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.

Luo F, Cao J, Lu F, Zeng K, Ma W, Huang Y, Zhang L, Zhao H. Luo F, et al. Cancer Cell Int. 2021 Aug 28;21(1):458. doi: 10.1186/s12935-021-02162-w. Cancer Cell Int. 2021. PMID: 34454491 Free PMC article.

9

Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.

Luo F, Zeng KM, Cao JX, Zhou T, Lin SX, Ma WJ, Yang YP, Zhang ZH, Lu FT, Huang Y, Zhao HY, Zhang L. Luo F, et al. Among authors: zeng km. Lipids Health Dis. 2021 Sep 20;20(1):109. doi: 10.1186/s12944-021-01538-1. Lipids Health Dis. 2021. PMID: 34544437 Free PMC article.

10

Correction to: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.

Luo F, Cao J, Lu F, Zeng K, Ma W, Huang Y, Zhang L, Zhao H. Luo F, et al. Cancer Cell Int. 2022 Jan 29;22(1):46. doi: 10.1186/s12935-022-02458-5. Cancer Cell Int. 2022. PMID: 35093085 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page